Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,803.50
-46.90 (-1.65%)
Oct 23, 2026, 11:20 AM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 462.48 billion as of October 22, 2026. It is the 3,597th most valuable company in the world and the 206th biggest in India. Its market cap has increased by 46.01% in one year.
Market Cap
462.48B
Enterprise Value
431.73B
Revenue
67.25B
Global Rank
Country Rank
#206 India
PE Ratio
40.98
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 462.48B, an increase of 55.67%. That is a compound annual growth rate of 7.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 462.48B | 63.01% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.08T |
| Cipla | 1.06T |
| Mankind Pharma | 927.47B |
| Aurobindo Pharma | 904.55B |
| Glenmark Pharmaceuticals | 619.23B |
| Alkem Laboratories | 591.61B |
| Ipca Laboratories | 490.49B |
| Ajanta Pharma | 408.33B |